We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Apotex Prohibited From Selling Generic Pulmicort
Apotex Prohibited From Selling Generic Pulmicort
May 26, 2009
A federal judge in a patent dispute has issued an injunction that prohibits Apotex from selling its generic version of AstraZeneca’s Pulmicort Respules to treat pediatric asthma.